NCT02973243View on ClinicalTrials.gov

The Vital Signs to Identify, Target, and Assess Level (VITAL) Care Study III

CompletedOBSERVATIONAL
Enrollment

446

Participants

Timeline

Start Date

October 5, 2016

Primary Completion Date

February 28, 2017

Study Completion Date

February 28, 2017

Conditions
Cardiac ArrestRenal FailureRespiration FailureMyocardial InfarctionSevere Sepsis
Interventions
DEVICE

Automatic RR Measurement

Different newly developed respiration rate sensors are applied at the bedside during the intervention phase which send data to the IntelliVue Guardian System.

Trial Locations (1)

Unknown

Ysbyty Gwynedd Hospital, Bangor

Sponsors

Lead Sponsor

Philips Healthcare
All Listed Sponsors
lead

Philips Healthcare

INDUSTRY